NASDAQ:ATRS

Antares Pharma SEC Filings & 10K Form

$4.06
+0.02 (+0.50 %)
(As of 04/14/2021 03:59 PM ET)
Add
Compare
Today's Range
$4.00
Now: $4.06
$4.16
50-Day Range
$3.97
MA: $4.22
$4.78
52-Week Range
$2.39
Now: $4.06
$5.07
Volume52,740 shs
Average Volume1.28 million shs
Market Capitalization$682.73 million
P/E Ratio67.68
Dividend YieldN/A
Beta1.44

SEC Filings

Antares Pharma (NASDAQ:ATRS) SEC Filings

DateFilerForm TypeView
03/12/2021
6:04 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:01 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2021
5:33 PM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
5:32 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
5:31 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
3:32 PM
Antares Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/02/2021
6:30 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2021
6:12 PM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
6:11 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
6:08 PM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
6:07 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
5:53 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
7:11 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
7:21 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
7:12 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2020
6:04 AM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
7:18 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
6:31 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
7:56 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2020
3:30 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
6:30 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2020
4:19 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
8:15 PM
Antares Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:15 PM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:12 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:09 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:05 PM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:02 PM
Antares Pharma (Issuer)
Greenleaf Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:00 PM
Antares Pharma (Issuer)
GUETH ANTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:49 PM
Antares Pharma (Issuer)
ROCHE ROBERT P JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
5:42 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
5:30 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
5:27 PM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
5:24 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2020
3:43 PM
Antares Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2020
6:30 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2020
4:19 PM
Antares Pharma (Filer)
Form DEFA14A
04/27/2020
4:18 PM
Antares Pharma (Filer)
Form DEF 14A
04/09/2020
3:24 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2020
2:36 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2020
6:30 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2020
5:28 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
5:27 PM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
5:24 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
12:16 PM
Antares Pharma (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G/A
02/11/2020
6:07 AM
Antares Pharma (Subject)
UBS Group AG (Filed by)
Form SC 13G/A
01/27/2020
6:22 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
5:07 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
8:06 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
5:06 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:57 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
6:24 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
6:21 PM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
6:15 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
4:35 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
4:32 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
6:30 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
6:01 AM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
5:59 AM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
4:00 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
6:05 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
4:03 PM
Antares Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/05/2019
3:00 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2019
7:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2019
3:00 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2019
9:01 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
4:51 PM
Antares Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:49 PM
Antares Pharma (Issuer)
Greenleaf Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:46 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:43 PM
Antares Pharma (Issuer)
ROCHE ROBERT P JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:41 PM
Antares Pharma (Issuer)
GUETH ANTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:39 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:36 PM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:34 PM
Antares Pharma (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:32 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:30 PM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:28 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
4:43 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
4:40 PM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
4:38 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
4:14 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
4:13 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
4:30 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
6:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:26 PM
Antares Pharma (Filer)
Form DEF 14A
04/10/2019
4:49 PM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
4:13 PM
Antares Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2019
5:02 PM
Antares Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
4:55 PM
Antares Pharma (Issuer)
Smith Karen L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/05/2019
9:01 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
9:33 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
4:30 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
6:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2019
5:47 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:45 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
4:30 PM
Antares Pharma (Subject)
UBS Group AG (Filed by)
Form SC 13G
02/14/2019
1:27 PM
Antares Pharma (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G/A
02/04/2019
9:07 AM
Antares Pharma (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/07/2019
6:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2018
5:49 PM
Antares Pharma (Issuer)
Greenleaf Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.